Temozolomide Capsule
Pricing Report NDC 47335-891-21

Latest NADAC: $4.80834 per EA · Effective May 22, 2024

Current Package Pricing Information

The latest wholesale acquisition cost for Temozolomide (NDC 47335-891-21) is $4.80834 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 22, 2024.

As a a human prescription drug provided by Sun Pharmaceutical Industries, Inc., this medication is distributed in a 1 BOTTLE in 1 CARTON / 14 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$4.80834
Per EA

Effective Date
May 22, 2024
Data Status
As of Aug 14, 2024
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE in 1 CARTON / 14 CAPSULE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2014, the NADAC wholesale price for (NDC ) has moved within a range of $0.87977 to $31.90119 per EA. Over this 12 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.8798 - $31.9012
Market Volatility
3,526.08% Variance
Latest Trend
No Change

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $0.87977 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Aug 19, 2026 $0.87977 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 22, 2026 $0.87977 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 22, 2026 $0.87977 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jun 17, 2026 $1.15270 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jun 17, 2026 $1.15270 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 20, 2026 $1.42564 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 20, 2026 $1.42564 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 22, 2026 $1.83575 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 22, 2026 $1.83575 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 18, 2026 $1.90435 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 18, 2026 $1.90435 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026